Yi Qian, Ph.D., is Vice President and Head of Integrated Evidence and Advanced Patient Modeling at Johnson & Johnson Innovative Medicine. She leads a pioneering mission to de-risk clinical development and accelerate regulatory decisions by building a next-generation, AI-powered evidence engine.

Her team is at the forefront of creating intelligent models that integrate multimodal data, causal reasoning, and digital twin approaches to generate decision-grade insights. With over two decades of experience spanning R&D and commercial roles across US, international, and global functions, Dr. Qian is a recognized leader in shaping regulatory-facing strategies and deploying data-driven solutions that impact both clinical development and patient care.

Previously, as VP and Head of Global Real-World Evidence (RWE) in Commercial Strategy, she developed innovative evidence solutions to accelerate product launches and clinical adoption. Dr. Qian is a passionate advocate for a data-driven decision-making culture that bridges the gap between advanced analytics and patient-centric healthcare.